Translating the Biology of Aging into New Therapeutics for Alzheimer’s Disease: Senolytics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Translating the Biology of Aging into New Therapeutics for Alzheimer’s Disease: Senolytics ; volume:10 ; number:4 ; day:24 ; month:10 ; year:2023 ; pages:633-646 ; date:11.2023
The journal of prevention of Alzheimer's disease ; 10, Heft 4 (24.10.2023), 633-646, 11.2023
- Creator
-
Riessland, M.
Orr, Miranda E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2023.104
- URN
-
urn:nbn:de:101:1-2024011208523556554252
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Riessland, M.
- Orr, Miranda E.
- SpringerLink (Online service)
Other Objects (12)
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics